| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Nov 2025 | 4 Nov 2025 |
| Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ended 30th September 2025 Pursuant to Regulation 30 of the Listing Regulations, this is to inform you that the Board of Directors of the Company, at its meeting held today i.e. on Thursday, 13th November, 2025, have approved the Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September, 2025 together with the Limited Review Report issued by the Statutory Auditors, M/s. Krishaan & Co., Chartered Accountants which are attached herewith. (As per BSE Announcement dated on: 13.11.2025) | ||
| Board Meeting | 1 Aug 2025 | 26 Jul 2025 |
| Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve unaudited financial results for the quarter ended 30th June 2025. Please refer to the attachment. (As Per BSE Announcement Dated on: 01/08/2025) | ||
| Board Meeting | 20 May 2025 | 15 May 2025 |
| Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve audited standalone and consolidated financial results for the quarter and year ended 31.03.2025 Board Meeting Outcome for Outcome Of The Board Meeting Under Reg 30 Of SEBI (LODR) (As Per BSE Announcement Dated on: 20/05/2025) | ||
| Board Meeting | 14 Feb 2025 | 7 Feb 2025 |
| THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve unaudited financial results and Limited Review Report for the Quarter and Nine months ended 31st December, 2024. Please refer to the attachment. (As Per BSE Announcement Dated on: 14/02/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.